KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other Non-Current Liabilities (2016 - 2025)

Pacira BioSciences has reported Other Non-Current Liabilities over the past 16 years, most recently at $20.6 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $20.6 million for Q4 2025, up 1.64% from a year ago — trailing twelve months through Dec 2025 was $20.6 million (up 1.64% YoY), and the annual figure for FY2025 was $20.6 million, up 1.64%.
  • Other Non-Current Liabilities for Q4 2025 was $20.6 million at Pacira BioSciences, down from $25.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for PCRX hit a ceiling of $57.6 million in Q4 2021 and a floor of $7.6 million in Q3 2021.
  • Median Other Non-Current Liabilities over the past 5 years was $16.3 million (2022), compared with a mean of $20.1 million.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 704.89% in 2021 and later tumbled 83.21% in 2022.
  • Pacira BioSciences' Other Non-Current Liabilities stood at $57.6 million in 2021, then tumbled by 83.21% to $9.7 million in 2022, then surged by 40.38% to $13.6 million in 2023, then soared by 49.13% to $20.2 million in 2024, then increased by 1.64% to $20.6 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $20.6 million (Q4 2025), $25.3 million (Q3 2025), and $25.2 million (Q2 2025) per Business Quant data.